Evogene
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$6.61M
-0.8
-2.85
$5.58M
117
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
emptyResult
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Recently from Cashu
Evogene Unveils AI Innovations at BIO-Europe Spring 2026 Conference in Lisbon
Evogene Showcases AI-Driven Innovations at BIO-Europe Spring 2026 Conference Evogene Ltd., a leader in computational chemistry, prepares to showcase its cutting-edge advancements in AI-driven small-mo…
Evogene to Present AI Innovations at BIO-Europe Spring 2026 Conference in Lisbon
Evogene Showcases AI-Driven Innovations at BIO-Europe Spring 2026 Conference Evogene Ltd. announces its participation in the highly anticipated BIO-Europe Spring 2026 conference, running from March 23…
Evogene Reports Strong Q4 Growth Driven by Innovative Agtech Solutions and Sustainability Focus
Evogene Shows Promising Growth in Q4 Driven by Innovative Agtech Solutions Evogene, a biotechnology company specializing in agricultural solutions, reports a noteworthy growth trajectory in its Q4 ear…
Evogene Reports Growth in Sustainable Agriculture Solutions Amid Rising Demand for Agtech Innovations
Evogene: Pioneering Innovations in Sustainable Agriculture In its recent Q4 earnings announcement, Evogene (NASDAQ:EVGN) showcases its growth in the biotechnological solutions sector, particularly aim…